News

January 2, 2019January 3, 2019

Apulmiq’s Benefits Confirmed in Third-party Evaluation

News

A third-party evaluation (TPE) confirmed the efficacy of the bronchiectasis treatment candidate Apulmiq found in Phase 3 trials, Aradigm, the developer of the therapy, recently announced. Apulmiq, previously known as Linhaliq and Pulmaquin, ... Read more

December 21, 2018December 21, 2018

Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish

News

Cash-strapped governments across the 28-member European Union are struggling to control runaway healthcare expenditures — at exactly the same time as the promise of new but expensive therapies to treat ... Read more

December 20, 2018December 20, 2018

Mycobacterium abscessus Gave Rise to Autoimmune Disorder in Bronchiectasis Patient, Report Says

News

A first case of an autoimmune disorder characterized by inflammation of blood vessels in a bronchiectasis patient infected with Mycobacterium abscessus highlights the therapeutic challenges in managing nontuberculous mycobacteria (NTM) infections. ... Read more

December 13, 2018December 13, 2018

Zambon’s Inhalable Antibiotic for Non-CF Bronchiectasis Gets Fast Track, QIDP Status from FDA

News

The U.S. Food and Drug Administration (FDA) granted Qualified Infectious Diseases Product (QIDP) and Fast Track designations to Zambon’s inhalable colistimethate sodium product to help prevent non-cystic fibrosis bronchiectasis (NCFBE) ... Read more

December 6, 2018December 6, 2018

‘Vascular Pruning’ Affects Lung Function in Smokers With Bronchiectasis

News

A recent study comparing computed tomography (CT) scan data found that smokers with bronchiectasis have a greater loss of blood vessels in the lungs, a process known as vascular pruning. ... Read more

November 29, 2018November 29, 2018

Pus in Sputum Associated with Disease-prone Bacteria in Bronchiectasis

News

The presence of pus (purulence) in sputum samples from bronchiectasis patients is associated with an imbalance in microbial communities and a higher prevalence of potential disease-prone bacteria, a new study ... Read more

November 15, 2018November 15, 2018

Certain Autoantibodies Linked to P. aeruginosa Infection in Bronchiectasis Patients, Study Suggests

News

Production of autoantibodies against a particular protein called bactericidal/permeability-increased protein (BPI) is strongly associated with chronic Pseudomonas aeruginosa infection in patients with bronchiectasis, a study has found. BPI is an anti-microbial protein ... Read more

November 8, 2018November 8, 2018

New Probe Allows Safe, Easy Visualization of Infectious Bacteria in Lungs, Study Shows

News

A newly developed fluorescent probe allows the detection of infectious bacteria in human airways and lung’s air sacs within minutes, a study shows. This innovative diagnostic strategy was found to ... Read more

November 1, 2018November 1, 2018

B. bronchiseptica Infection Causes Varied Symptoms in Non-CF Bronchiectasis Patients, Case Series Shows

News

Infection with the bacterium Bordetella bronchiseptica can have varying symptoms and be difficult to eradicate in patients with non-cystic fibrosis (CF) bronchiectasis, a case series shows. Because people, particularly those with compromised immune ... Read more

October 30, 2018October 30, 2018

#NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach

News

With the U.S. midterm elections now less than two weeks away, patient advocacy groups are solidly focused on a range of hot-button issues, from the Orphan Drug Tax Creditand affordable ... Read more